Quanterix to acquire Akoya Biosciences in stock deal; exchange ratio 0.318

Quanterix Corp

Akoya shareholders to receive 0.318 Quanterix shares per share; no cash consideration except for fractional shares.
Voting agreements from ~55.9% of Akoya stock and ~6.2% of Quanterix stock; lock-up agreements cover ~35.7% of QTRX shares for 90 days.
Termination fees: $7M from Akoya, $9M from Quanterix; Quanterix may provide $30M bridge convertible notes after March 15, 2025.
Expected close by July 9, 2025 (extendable to Jan 9, 2026); Akoya to nominate two directors to Quanterix board.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.